These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11177743)

  • 21. Immunotherapy for colorectal cancer.
    Midgley RS; Kerr DJ
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunology of colorectal cancer.
    Zbar AP
    Surg Oncol; 2004; 13(2-3):45-53. PubMed ID: 15572086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine-induced apoptosis: a novel clinical trial end point?
    Amin S; Robins RA; Maxwell-Armstrong CA; Scholefield JH; Durrant LG
    Cancer Res; 2000 Jun; 60(12):3132-6. PubMed ID: 10866299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.
    Birebent B; Somasundaram R; Purev E; Li W; Mitchell E; Hoey D; Bloom E; Mastrangelo M; Maguire H; Harris DT; Staib L; Braumuller H; Leeser C; Kuttner N; Beger HG; Herlyn D
    Crit Rev Oncol Hematol; 2001; 39(1-2):107-13. PubMed ID: 11418307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen.
    Pervin S; Chakraborty M; Bhattacharya-Chatterjee M; Zeytin H; Foon KA; Chatterjee SK
    Cancer Res; 1997 Feb; 57(4):728-34. PubMed ID: 9044852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.
    Samonigg H; Wilders-Truschnig M; Loibner H; Plot R; Rot A; Kuss I; Werner G; Stöger H; Wrann M; Herlyn D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):271-7. PubMed ID: 1451329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for colorectal cancer: a challenge to clinical trial design.
    Midgley R; Kerr D
    Lancet Oncol; 2000 Nov; 1():159-68. PubMed ID: 11905654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.
    Correale P; Cusi MG; Micheli L; Nencini C; Del Vecchio MT; Torino F; Aquino A; Bonmassar E; Francini G; Giorgi G
    Invest New Drugs; 2006 Mar; 24(2):99-110. PubMed ID: 16502353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiotypic antibody immunotherapy of cancer.
    Chatterjee MB; Foon KA; Köhler H
    Cancer Immunol Immunother; 1994 Feb; 38(2):75-82. PubMed ID: 8306369
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal antibodies for cancer immunotherapy.
    Weiner LM; Dhodapkar MV; Ferrone S
    Lancet; 2009 Mar; 373(9668):1033-40. PubMed ID: 19304016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy of colorectal cancer: new perspectives after a long path.
    Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
    Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotype antibody vaccine therapies of cancer.
    Bhattacharya-Chatterjee M; Foon KA
    Cancer Treat Res; 1998; 94():51-68. PubMed ID: 9587682
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
    Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype.
    Wettendorff M; Iliopoulos D; Schmoll E; Koprowski H; Herlyn D
    J Immunol Methods; 1989 Jan; 116(1):105-15. PubMed ID: 2783712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
    Chatterjee SK; Tripathi PK; Chakraborty M; Yannelli J; Wang H; Foon KA; Maier CC; Blalock JE; Bhattacharya-Chatterjee M
    Cancer Res; 1998 Mar; 58(6):1217-24. PubMed ID: 9515808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
    Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
    Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
    Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
    Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
    Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
    Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.